Human Psychopharmacology : Impact Factor & More
eISSN: 1099-1077pISSN: 0885-6222
Share this on:
Key Metrics
CiteScore 
2.8
Impact Factor
< 5
SJR
Q2Neurology
SNIP
0.85
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Human Psychopharmacology
Human Psychopharmacology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1986 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Human Psychopharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Human Psychopharmacology
Investigating Hypo-Egoic Features: Ayahuasca's Psychedelic Path Versus Meditation's Mindful Journey.
- 1 May 2026
- Human psychopharmacology
Efficacy of Glucagon-Like Peptide-1 Receptor Agonists for Psychological Well-Being and Depressive Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- 1 May 2026
- Human psychopharmacology
Rivastigmine for Behavioural Symptoms in Parkinson's Disease: Evidence and Open Questions.
- 1 May 2026
- Human psychopharmacology
Psychopathological Concomitants and Motivations Related to Misuse of Non-Steroidal Anti-Inflammatory Drugs and Paracetamol.
- 1 May 2026
- Human psychopharmacology
Reconceptualization of Drug Effects in Double Blind Randomized Placebo Controlled Trials for Psychiatric Illnesses: A Practical Suggestion.
- 1 May 2026
- Human psychopharmacology
Empagliflozin as an Alternative to Metformin for Antipsychotic-Related Weight Gain: Double-Blind Randomized Controlled Trial.
- 1 May 2026
- Human psychopharmacology
Investigating Hypo-Egoic Features: Ayahuasca's Psychedelic Path Versus Meditation's Mindful Journey.
- 1 May 2026
- Human psychopharmacology
Efficacy of Glucagon-Like Peptide-1 Receptor Agonists for Psychological Well-Being and Depressive Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- 1 May 2026
- Human psychopharmacology
Rivastigmine for Behavioural Symptoms in Parkinson's Disease: Evidence and Open Questions.
- 1 May 2026
- Human psychopharmacology
Psychopathological Concomitants and Motivations Related to Misuse of Non-Steroidal Anti-Inflammatory Drugs and Paracetamol.
- 1 May 2026
- Human psychopharmacology
Reconceptualization of Drug Effects in Double Blind Randomized Placebo Controlled Trials for Psychiatric Illnesses: A Practical Suggestion.
- 1 May 2026
- Human psychopharmacology
Empagliflozin as an Alternative to Metformin for Antipsychotic-Related Weight Gain: Double-Blind Randomized Controlled Trial.
- 1 May 2026
- Human psychopharmacology
FAQs on Human Psychopharmacology
How long has Human Psychopharmacology been actively publishing? 
What is the publishing frequency of Human Psychopharmacology?
How many articles did Human Psychopharmacology publish last year?
What is the eISSN & pISSN for Human Psychopharmacology?
What is Citescore for Human Psychopharmacology?
What is SNIP score for Human Psychopharmacology?
What is the SJR for Human Psychopharmacology?
Who is the publisher of Human Psychopharmacology?
